Skip to main content
Thorax logoLink to Thorax
. 1984 Nov;39(11):857–861. doi: 10.1136/thx.39.11.857

Cryptogenic fibrosing alveolitis: pattern of disease in the lung.

P H Wright, M Buxton-Thomas, L Kreel, S J Steel
PMCID: PMC459937  PMID: 6505992

Abstract

The distribution of disease has been studied in 10 patients with histologically confirmed cryptogenic fibrosing alveolitis by means of computed tomography of the lungs, gallium 67 uptake scintigraphy, and ventilation and perfusion scintigraphy. The findings of computed tomography and scintigraphy showed no correlation with the UICC/Cincinnati grades of the plain chest radiographs, even when these were supplemented with information from lateral and oblique chest films. Computed tomography showed subpleural shadowing in every patient except one who had responded well to corticosteroid treatment. Subpleural shadowing was commoner in the inferior and posterior parts of the lung lobes and was commonest in the posterior lower subpleural areas. The central lung showed three types of change--firstly, a dense shadowing, which was sometimes associated with much increased gallium uptake; secondly, dilated smaller airways with small bullae, suggesting airway disease; and, thirdly, gross bullous change.

Full text

PDF
857

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bateman E. D., Turner-Warwick M., Haslam P. L., Adelmann-Grill B. C. Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens. Thorax. 1983 Feb;38(2):93–101. doi: 10.1136/thx.38.2.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Crystal R. G., Gadek J. E., Ferrans V. J., Fulmer J. D., Line B. R., Hunninghake G. W. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med. 1981 Mar;70(3):542–568. doi: 10.1016/0002-9343(81)90577-5. [DOI] [PubMed] [Google Scholar]
  3. GAENSLER E. A., MOISTER V. B., HAMM J. OPEN-LUNG BIOPSY IN DUFFUSE PULMONARY DISEASE. N Engl J Med. 1964 Jun 18;270:1319–1331. doi: 10.1056/NEJM196406182702501. [DOI] [PubMed] [Google Scholar]
  4. Gaensler E. A., Carrington C. B. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg. 1980 Nov;30(5):411–426. doi: 10.1016/s0003-4975(10)61291-x. [DOI] [PubMed] [Google Scholar]
  5. Kreel L. Computerized tomography using the EMI general purpose scanner. Br J Radiol. 1977 Jan;50(589):2–14. doi: 10.1259/0007-1285-50-589-2. [DOI] [PubMed] [Google Scholar]
  6. LIVINGSTONE J. L., LEWIS J. G., REID L., JEFFERSON K. E. DIFFUSE INTERSTITIAL PULMONARY FIBROSIS.A CLINICAL, RADIOLOGICAL, AND PATHOLOGICAL STUDY BASED ON 45 PATIENTS. Q J Med. 1964 Jan;33:71–103. [PubMed] [Google Scholar]
  7. Line B. R., Fulmer J. D., Reynolds H. Y., Roberts W. C., Jones A. E., Harris E. K., Crystal R. G. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: Correlation and physiologic and morphologic features and bronchoalveolar lavage. Am Rev Respir Dis. 1978 Aug;118(2):355–365. doi: 10.1164/arrd.1978.118.2.355. [DOI] [PubMed] [Google Scholar]
  8. Steel S. J., Winstanley D. P. Trephine biopsy for diffuse lung lesions. Br Med J. 1967 Jul 1;3(5556):30–32. doi: 10.1136/bmj.3.5556.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Steel S. J., Winstanley D. P. Trephine biopsy of the lung and pleura. Thorax. 1969 Sep;24(5):576–584. doi: 10.1136/thx.24.5.576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wright P. H., Heard B. E., Steel S. J., Turner-Warwick M. Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features. Br J Dis Chest. 1981 Jan;75(1):61–70. doi: 10.1016/s0007-0971(81)80008-3. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES